A cash pay model is a tool to make healthcare better, and tools are only as good as how we use them. Cost Plus Drugs is a glimpse of what that looks like for prescription drugs. The GLP-1 story I wrote about last week is a glimpse of what it looks like for a specific drug class. The LASIK story is what it can look like for a medical procedure. The healthcare system we have is the way it is for a lot of historical and political reasons, and none of this is going to change overnight. But the trend that we’re seeing is real and worth learning about - sometimes people paying directly for the aspect of medicine that they want brings prices down or improves the experience enough that we’re happy to pay the extra cost.